Brain, Stroke and Kidney (Contributions to Nephrology Vol.179) (2013. 134 S. 21 fig., 20 tab. 249 mm)

個数:

Brain, Stroke and Kidney (Contributions to Nephrology Vol.179) (2013. 134 S. 21 fig., 20 tab. 249 mm)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版
  • 商品コード 9783318023510

Full Description

Chronic kidney disease (CKD) is an established risk factor for cardiovascular diseases. Stroke, on the other hand, is not only a major player in cardiovascular disease, but it also has strong two-way relationships with CKD. Moreover, subclinical cerebral abnormalities are also associated with CKD. But despite all these connections, the cerebro-renal interaction has so far not received much attention. This book includes easily understandable reviews on brain, stroke and kidney by both experts in nephrology and neurology. Examined are underlying concepts for cerebro-renal interaction, risk of clinical and subclinical brain damage in CKD patients, primary prevention and acute/chronic management for stroke patients with CKD and end-stage kidney disease. This book promotes not only further understanding and a multidisciplinary collaboration between nephrologists and neurologists, but it is also of interest for neurosurgeons and cardiologists.

Contents

Introduction; Cerebrorenal Interaction and Stroke: Toyoda, K.; Underlying Concepts for Cerebrorenal Interaction; Inhibition of the Renin-Angiotensin-Aldosterone System for Cerebrorenal Protection: Lambers Heerspink, H.J.; Obesity and Heart Failure as a Mediator of the Cerebrorenal Interaction: Jindal, A.; Whaley-Connell, A.; Sowers, J.R.; Risk of Clinical and Subclinical Brain Damage in Kidney Disease; Subclinical Cerebral Abnormalities in Chronic Kidney Disease: Yao, H.; Takashima, Y.; Hashimoto, M.; Uchino, A.; Yuzuriha, T.; Carotid Atherosclerosis in Kidney Disease: Kokubo, Y.; Kidney Disease and Cognitive Function: Elias, M.F.; Dore, G.A.; Davey, A.; Risk of Stroke in Kidney Disease: Ninomiya, T.; Primary Prevention of Stroke in Kidney Disease; Role of 24-Hour Blood Pressure Management in Preventing Kidney Disease and Stroke: Nagai, M.; Hoshide, S.; Kario, K.; Preventing Stroke and Systemic Embolism in Renal Patients with Atrial Fibrillation: Focus on Anticoagulation: Ahmad, Y.; Lip, G.Y.H.; Management for Stroke in Kidney Disease; Stroke Features and Management in Patients with Chronic Kidney Disease: Kamouchi, M.; Stroke Feature and Management in Dialysis Patients: Iseki, K.; Thrombolysis and Hyperacute Reperfusion Therapy for Stroke in Renal Patients: Hirano, T.; Antiplatelet Therapy for Preventing Stroke in Patients with Chronic Kidney Disease: Kim, S.J.; Bang, O.Y.

最近チェックした商品